Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin for Glabellar Frown Lines
NCT00770211Phase 3Completed
- Sponsor
- Merz
- Start
- Oct 2008
- Primary completion
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of incobotulinumtoxinA in glabellar rhytides, sponsored by Merz. Started Oct 2008; status: completed.
02
Drugs
incobotulinumtoxinA
03
Conditions
glabellar rhytides
Beyond the preview
Go deeper on NCT00770211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00770211.